Latest filing published 30 Jun 2023 for Cano Health, Inc., €168k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Richard Aguilar: trading record in brief
Richard Aguilar is a declared insider of Cano Health, Inc. (senior executive), with filings sourced from SEC (Form 4). Between 25 August 2021 and 29 June 2023, the trades on record add up to 21 filings.
Both buying and selling appear: 3 purchases worth €1.3M, against 6 sales worth €2.3M. Taken together, the sales exceed the purchases by €990k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 6 share grants. In 2023 alone, the filings show no purchases and 6 sales.
In size, the median ticket on the buying side is €521k. Clusters matter here: 3 out of 3 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
Most recently, on 30 June 2023, the filings show an open-market sale worth €482k in Cano Health, Inc. The most recent open-market purchase was published on 1 September 2021, 1,895 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Richard Aguilar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 150,000 shares@ US$1.2225.8% of flowClass A Common StockSEC:0001209191-23-040344:0
- 550,000 shares0Class A Common StockSEC:0001209191-23-040036:0
- 275,940 shares@ US$1.290711.4% of flowClass A Common StockSEC:0001209191-23-036903:5
- 100,000 shares@ US$1.37764.4% of flowClass A Common StockSEC:0001209191-23-036903:6
- 500,000 shares@ US$1.423322.9% of flowClass A Common StockSEC:0001209191-23-036903:7
- 600,000 shares0Class A Common StockSEC:0001209191-23-036903:1
- 400,000 shares@ US$1.32117.1% of flowClass A Common StockSEC:0001209191-23-036903:2
- 675,940 shares0Class A Common StockSEC:0001209191-23-036903:0
- 600,000 shares0Class A Common StockSEC:0001209191-23-036903:3
- 600,000 shares0Class A Common StockSEC:0001209191-23-036903:4
- 231,008 sharesClass A Common StockSEC:0000950170-23-026062:0
- 120,116 sharesClass A Common StockSEC:0000899243-23-010576:0
- 27,010 shares@ US$1.07520.9% of flowClass A Common StockSEC:0000899243-23-001341:0
- 171,641 sharesClass A Common StockSEC:0000899243-22-011461:0
- 200,000 sharesClass A Common StockSEC:0000899243-22-002632:0
- 119,407 sharesClass A Common StockSEC:0000899243-21-049383:0
- 285,333 sharesClass A Common StockSEC:0000899243-21-037542:0
- 1,749 shares@ US$11.930.8% of flowClass A Common StockSEC:0000899243-21-034733:0Canonical exit: 28 Nov 2021 (T+90)
- 51,393 shares@ US$11.9322.2% of flowClass A Common StockSEC:0000899243-21-034608:0Canonical exit: 23 Nov 2021 (T+90)
19 of 19 declarations